CRISPR Therapeutics AG Statistics
Total Valuation
CRSP has a market cap or net worth of $4.92 billion. The enterprise value is $3.18 billion.
Important Dates
The last earnings date was Monday, November 10, 2025, before market open.
| Earnings Date | Nov 10, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
CRSP has 95.30 million shares outstanding. The number of shares has increased by 5.48% in one year.
| Current Share Class | 95.30M |
| Shares Outstanding | 95.30M |
| Shares Change (YoY) | +5.48% |
| Shares Change (QoQ) | +4.86% |
| Owned by Insiders (%) | 0.52% |
| Owned by Institutions (%) | 74.82% |
| Float | 94.80M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 117.67 |
| Forward PS | 69.28 |
| PB Ratio | 2.53 |
| P/TBV Ratio | 2.57 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 83.01 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 16.22, with a Debt / Equity ratio of 0.11.
| Current Ratio | 16.22 |
| Quick Ratio | 16.10 |
| Debt / Equity | 0.11 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -25.33% and return on invested capital (ROIC) is -13.92%.
| Return on Equity (ROE) | -25.33% |
| Return on Assets (ROA) | -13.28% |
| Return on Invested Capital (ROIC) | -13.92% |
| Return on Capital Employed (ROCE) | -22.49% |
| Revenue Per Employee | $97,550 |
| Profits Per Employee | -$1.24M |
| Employee Count | 393 |
| Asset Turnover | 0.02 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, CRSP has paid $3.72 million in taxes.
| Income Tax | 3.72M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +0.80% in the last 52 weeks. The beta is 1.72, so CRSP's price volatility has been higher than the market average.
| Beta (5Y) | 1.72 |
| 52-Week Price Change | +0.80% |
| 50-Day Moving Average | 61.68 |
| 200-Day Moving Average | 50.42 |
| Relative Strength Index (RSI) | 39.70 |
| Average Volume (20 Days) | 2,560,862 |
Short Selling Information
The latest short interest is 23.19 million, so 24.33% of the outstanding shares have been sold short.
| Short Interest | 23.19M |
| Short Previous Month | 21.03M |
| Short % of Shares Out | 24.33% |
| Short % of Float | 24.46% |
| Short Ratio (days to cover) | 9.48 |
Income Statement
In the last 12 months, CRSP had revenue of $38.34 million and -$488.30 million in losses. Loss per share was -$5.58.
| Revenue | 38.34M |
| Gross Profit | -430.67M |
| Operating Income | -478.14M |
| Pretax Income | -484.58M |
| Net Income | -488.30M |
| EBITDA | -459.48M |
| EBIT | -478.14M |
| Loss Per Share | -$5.58 |
Full Income StatementBalance Sheet
The company has $1.92 billion in cash and $211.02 million in debt, giving a net cash position of $1.73 billion or $18.19 per share.
| Cash & Cash Equivalents | 1.92B |
| Total Debt | 211.02M |
| Net Cash | 1.73B |
| Net Cash Per Share | $18.19 |
| Equity (Book Value) | 1.92B |
| Book Value Per Share | 20.41 |
| Working Capital | 1.81B |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$302.49 million and capital expenditures -$651,000, giving a free cash flow of -$303.14 million.
| Operating Cash Flow | -302.49M |
| Capital Expenditures | -651,000 |
| Free Cash Flow | -303.14M |
| FCF Per Share | -$3.18 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -1,247.21% |
| Pretax Margin | -1,263.99% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CRSP does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -5.48% |
| Shareholder Yield | -5.48% |
| Earnings Yield | -9.93% |
| FCF Yield | -6.17% |
Dividend DetailsAnalyst Forecast
The average price target for CRSP is $71.50, which is 38.62% higher than the current price. The consensus rating is "Buy".
| Price Target | $71.50 |
| Price Target Difference | 38.62% |
| Analyst Consensus | Buy |
| Analyst Count | 19 |
| Revenue Growth Forecast (5Y) | 128.98% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CRSP has an Altman Z-Score of 6.63 and a Piotroski F-Score of 1.
| Altman Z-Score | 6.63 |
| Piotroski F-Score | 1 |
